Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.27 USD | -0.12% | +2.14% | -32.41% |
May. 21 | Sector Update: Financial Stocks Higher Late Afternoon | MT |
May. 21 | Sector Update: Financial Stocks Edge Up Tuesday Afternoon | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company is in debt and has limited leeway for investment
- The company is not the most generous with respect to shareholders' compensation.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-32.41% | 7.59B | B- | ||
+7.07% | 102B | B | ||
+9.49% | 101B | B- | ||
-11.17% | 85.47B | B+ | ||
+21.65% | 75.42B | D+ | ||
+20.52% | 34.4B | B | ||
+20.29% | 30.21B | B | ||
+10.96% | 28.89B | A | ||
-3.22% | 16.59B | C+ | ||
-14.98% | 14.22B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GL Stock
- Ratings Globe Life Inc.